
Amphastar Pharmaceuticals AMPH
$ 21.26
-0.56%
Annual report 2025
added 02-26-2026
Amphastar Pharmaceuticals Historical Prices 2011-2026 | AMPH
Annual Historical Prices Amphastar Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.7 | 27 | 46.6 | 36.2 | 27.7 | 17.5 | 15.4 | 24.9 | 18.4 | 15.5 | 10.5 | 14 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.6 | 10.5 | 23.4 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
311 | $ 334.25 | -1.52 % | $ 43.8 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.69 | 1.94 % | $ 8.88 B | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
6.67 | $ 7.57 | -13.39 % | $ 74.8 M | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 4.76 | 1.17 % | $ 761 M | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Cabaletta Bio
CABA
|
2.82 | $ 3.3 | 1.23 % | $ 332 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
91.2 | $ 99.6 | 1.21 % | $ 27.2 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.07 | 0.49 % | $ 5.05 M | ||
|
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.3 | $ 1.55 | -0.64 % | $ 399 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
4.37 | $ 4.18 | 0.84 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 24.43 | -2.63 % | $ 3.11 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.47 | -1.01 % | $ 391 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
CNS Pharmaceuticals
CNSP
|
2.39 | $ 2.7 | 2.27 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | ||
|
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Cidara Therapeutics
CDTX
|
23.4 | - | - | $ 1.41 B | ||
|
Akari Therapeutics, Plc
AKTX
|
0.12 | $ 4.6 | -0.65 % | $ 310 B | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | ||
|
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K |